FI760765A - - Google Patents

Info

Publication number
FI760765A
FI760765A FI760765A FI760765A FI760765A FI 760765 A FI760765 A FI 760765A FI 760765 A FI760765 A FI 760765A FI 760765 A FI760765 A FI 760765A FI 760765 A FI760765 A FI 760765A
Authority
FI
Finland
Application number
FI760765A
Inventor
Georg Rainer
Helmut Hein
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU72129A external-priority patent/LU72129A1/xx
Priority claimed from LU74400A external-priority patent/LU74400A1/xx
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of FI760765A publication Critical patent/FI760765A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70Nitro radicals
    • C07D307/71Nitro radicals attached in position 5
    • C07D307/72Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/74Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70Nitro radicals
    • C07D307/71Nitro radicals attached in position 5
    • C07D307/72Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/74Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals
    • C07D307/76Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals having carbonic acyl radicals or their thio or nitrogen analogues directly attached to the hydrazino or hydrazono radical, e.g. semicarbazides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FI760765A 1975-03-25 1976-03-23 FI760765A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU72129A LU72129A1 (fi) 1975-03-25 1975-03-25
LU74400A LU74400A1 (fi) 1976-02-20 1976-02-20

Publications (1)

Publication Number Publication Date
FI760765A true FI760765A (fi) 1976-09-26

Family

ID=26640174

Family Applications (1)

Application Number Title Priority Date Filing Date
FI760765A FI760765A (fi) 1975-03-25 1976-03-23

Country Status (12)

Country Link
US (1) US4093812A (fi)
JP (2) JPS51125387A (fi)
AT (1) ATA210876A (fi)
BE (1) BE839932A (fi)
DE (1) DE2612155A1 (fi)
DK (1) DK127876A (fi)
FI (1) FI760765A (fi)
FR (1) FR2305181A1 (fi)
GB (1) GB1507957A (fi)
NL (1) NL7603012A (fi)
NO (1) NO760996L (fi)
SE (1) SE7603554L (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE896678A (fr) * 1982-05-18 1983-11-07 Sandoz Sa Nouveaux derives de la 2 (1h)-pyridinone, leur preparation et leur utilisation comme medicaments.
EP0233287B1 (en) 1984-10-04 1991-01-30 Zenyaku Kogyo Kabushikikaisha 1,4-thiazine derivatives, process for their preparation, and cardiotonics containing the same
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
US6749721B2 (en) * 2000-12-22 2004-06-15 Kimberly-Clark Worldwide, Inc. Process for incorporating poorly substantive paper modifying agents into a paper sheet via wet end addition
WO2004037248A2 (en) * 2002-10-24 2004-05-06 Carex Sa Modulation of peroxisome proliferator activated receptors activity
EP1587473A4 (en) * 2002-12-27 2008-08-13 Novartis Vaccines & Diagnostic THIOSEMICARBAZONES ANTIVIRAL AND IMMUNOSTIMULANTS
WO2005061462A2 (en) * 2003-12-19 2005-07-07 Neurogen Corporation Diaryl pyrazole derivatives and their use as neurokinin-3 receptor modulators
US7122700B2 (en) * 2004-07-30 2006-10-17 Xerox Corporation Arylamine processes
US7670459B2 (en) * 2004-12-29 2010-03-02 Kimberly-Clark Worldwide, Inc. Soft and durable tissue products containing a softening agent
WO2006106052A1 (en) * 2005-04-05 2006-10-12 F. Hoffmann-La Roche Ag Pyrazoles
WO2008021088A2 (en) * 2006-08-08 2008-02-21 The Regents Of The University Of Californina Salicylanilides enhance oral delivery of therapeutic peptides
JP4940999B2 (ja) * 2007-02-28 2012-05-30 株式会社タンガロイ スローアウェイ式切削工具
JP4941082B2 (ja) * 2007-05-08 2012-05-30 株式会社タンガロイ スローアウェイ式切削工具およびこれに装着される切刃チップ
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
MX2018012541A (es) 2016-04-15 2019-01-17 Abbvie Inc Inhibidores de bromodominios.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758050A (fr) * 1969-10-28 1971-04-27 Geigy Ag J R Derives 5-nitro-furyliques et medicaments contenant de tels composes

Also Published As

Publication number Publication date
DE2612155A1 (de) 1976-10-14
US4093812A (en) 1978-06-06
NL7603012A (nl) 1976-09-28
FR2305181A1 (fr) 1976-10-22
JPS5248675A (en) 1977-04-18
JPS6032630B2 (ja) 1985-07-29
JPS51125387A (en) 1976-11-01
SE7603554L (sv) 1976-09-26
DK127876A (da) 1976-09-26
BE839932A (fr) 1976-09-23
ATA210876A (de) 1979-01-15
GB1507957A (en) 1978-04-19
NO760996L (fi) 1976-09-28

Similar Documents

Publication Publication Date Title
JPS5230193U (fi)
JPS51146448U (fi)
JPS5232795U (fi)
CH599465A5 (fi)
CH606730A5 (fi)
BG23454A1 (fi)
BG23488A1 (fi)
BG26465A1 (fi)
CH1608175A4 (fi)
CH582759A5 (fi)
CH586582A5 (fi)
CH586820A5 (fi)
BG22142A1 (fi)
CH591627A5 (fi)
BG22117A1 (fi)
CH593803A5 (fi)
CH595650A5 (fi)
CH595721A5 (fi)
CH595996A5 (fi)
CH596903A5 (fi)
CH597358A5 (fi)
CH597825A5 (fi)
CH597994A5 (fi)
CH598038A5 (fi)
CH592735A5 (fi)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: BYK GULDEN LOMBERG CHEMISCHE FABRIK